Work

Abstract CT244: A phase 1 study of IV MEDI5395, an oncolytic virus, in combination with durvalumab in patients with advanced solid tumors

Year: 2020

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2020-ct244

Authors: Grace K. Dy, Diwakar Davar, Evanthia Galanis, Danielle Townsley, Djuro Karanovic, Maria Schwaederle, Beth Kelly, Dmitriy Zamarin, Mitesh Borad, Kevin Harrington

Institutions: Roswell Park Comprehensive Cancer Center, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, Mayo Clinic, Memorial Sloan Kettering Cancer Center, Mayo Clinic in Arizona, Institute of Cancer Research

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3083125273

Cites:

Cited by: 6

Related to: 10